A little more than a decade after the advent of highly active antiretroviral therapy (HAART), it
is clear that the survival of HIV-infected individuals has substantially improved. However …

Past studies revealed that HIV infection may implicate diverse cardiac diseases such as
cardiomyopathy, coronary heart disease, cardiac neoplasms, endocarditis or pericarditis. In …

Systemic arterial hypertension HIV-induced endothelial dysfunction; vasculitis in small,
medium, and large vessels in the form of leukocytoclastic vasculitis; atherosclerosis …

Use of highly active antiretroviral therapy (HAART) for the treatment of human
immunodeficiency virus (HIV) infection is associated with the development of cardiovascular …

Highly active antiretroviral therapy has greatly reduced mortality among human
immunodeficiency virus (HIV)‐infected patients by delaying, and possibly preventing …

Life expectancy in HIV-infected individuals has been greatly enhanced through immunologic
restoration and virologic suppression resulting from antiretroviral therapy. Current clinical …

Patients with human immunodeficiency virus (HIV) infection are at increased risk of
developing coronary heart disease (CHD). Although factors potentially contributing to this …

Although rollout of combined antiretroviral treatment (cART) has blunted human
immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) onset, there …

BY DECREASING HIV replication and its coincident deleterious effects on the immune
system, highly active antiretroviral therapy (HAART) has increased the life expectancy of …

The emergence of chronic disease complications in controlled HIV disease has changed the
landscape of HIV clinical care. HIV infection confers an increased cardiovascular disease …